Kudo Biotechnology
Kudo Biotechnology is a private mRNA CDMO founded in 2023 and headquartered in Needham Heights, United States. It provides cGMP manufacturing solutions to mRNA therapeutics and vaccine developers, operating with 11-50 employees.
- Company typePrivate
- Founded2023
- HeadquartersNeedham Heights, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
Kudo Biotechnology firmographics
Firmographics- Name
- Kudo Biotechnology
- Website
- https://kudobio.com
- Company type
- Private
- Founded year
- 2023
- Headcount range
- 11–50 employees
- Short description
- Kudo Biotechnology is a private mRNA CDMO founded in 2023 and headquartered in Needham Heights, United States. It provides cGMP manufacturing solutions to mRNA therapeutics and vaccine developers, operating with 11-50 employees.
- Ownership category
- akta.pro rank
Kudo Biotechnology industry classification
Industry- Product category
- mRNA Contract Manufacturing (CDMO)
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- mRNA/LNP & Nucleic Acid Therapeutics CDMO (HLAGABAF)
- akta.pro secondary industry
- mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)
Keywords
Where Kudo Biotechnology is headquartered
LocationHeadquarters
- HQ city
- Needham Heights
- HQ country
- United States
- HQ region
- North America
Markets served
Kudo Biotechnology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Kudo Biotechnology product offering
Product offeringCore offering
Kudo Biotechnology is an mRNA CDMO company that provides cGMP manufacturing solutions to mRNA companies. It offers outsourced contract manufacturing services targeting developers of mRNA-based therapeutics and vaccines who require current Good Manufacturing Practice (cGMP)-compliant production capacity.
Differentiator
Problem solved
Functional benefit
Companies that use Kudo Biotechnology
Customer profileIdeal customer profiles1 record
Kudo Biotechnology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Kudo Biotechnology competitors and assessment
Company assessmentDirect peers
- TriLink BioTechnologies (Maravai LifeSciences): Specialist mRNA and nucleic-acid CDMO providing cGMP RNA, CleanCap capping reagents, and LNP manufacturing — the most direct functional peer to Kudo's stated offering.
- Aldevron (Danaher): CDMO producing plasmid DNA, mRNA, and recombinant proteins for cell and gene therapies — directly comparable as a nucleic-acid manufacturing services provider serving mRNA developers.
Broad incumbents
- BioNTech: mRNA platform leader that operates significant in-house manufacturing and has partnered on external CDMO needs — a relevant incumbent benchmark for mRNA manufacturing scale and capability.
- Lonza Group: Global large-molecule CDMO with growing mRNA and LNP manufacturing capabilities, providing scale-pricing benchmark and competitive dynamic against smaller mRNA-focused CDMOs.
- Thermo Fisher Scientific (Patheon): Diversified CDMO and life-sciences tools provider with biopharma services including nucleic acid and biologics manufacturing — sets competitive ceiling on scale and pricing for specialist CDMOs.
- Catalent: Major CDMO with biologics and nucleic-acid fill-finish capabilities, including services relevant to mRNA developers — represents the broader incumbent competitive set.
- Avid Bioservices: Biologics CDMO offering process development and cGMP manufacturing for mammalian and microbial products — adjacent reference point for a small-cap manufacturing services business.
- Asahi Kasei (Bionova Scientific): Global biopharma manufacturing services provider expanding into nucleic-acid and biologics CDMO — relevant as an international competitor scaling into mRNA-adjacent services.
Emerging players
- Curia: CDMO offering process development and manufacturing across small molecules, biologics, and emerging modalities — relevant mid-tier competitor for early-stage CDMO customers.
- Ginkgo Bioworks: Synthetic biology platform building nucleic-acid and cell-engineering capabilities with biopharma service offerings — emerging competitor for nucleic-acid manufacturing and mRNA-adjacent services.
Market position
Customer concentration
Kudo Biotechnology social profiles
Digital presenceKudo Biotechnology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kudo Biotechnology leadership team
Management profileNumber of profiles
Kudo Biotechnology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kudo Biotechnology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kudo Biotechnology
What does Kudo Biotechnology do?
Kudo Biotechnology is an mRNA CDMO company that provides cGMP manufacturing solutions to mRNA companies. It offers outsourced contract manufacturing services targeting developers of mRNA-based therapeutics and vaccines who require current Good Manufacturing Practice (cGMP)-compliant production capacity.
When was Kudo Biotechnology founded?
Kudo Biotechnology was founded in 2023. It employs 11 to 50 people.
Where is Kudo Biotechnology based?
Kudo Biotechnology is headquartered in Needham Heights, United States, in the North America region.
Who are Kudo Biotechnology's main competitors?
Direct peers on record are TriLink BioTechnologies (Maravai LifeSciences) and Aldevron (Danaher). Broad incumbents are BioNTech, Lonza Group, Thermo Fisher Scientific (Patheon), Catalent, Avid Bioservices and Asahi Kasei (Bionova Scientific). Emerging players are Curia and Ginkgo Bioworks.
Does Kudo Biotechnology have an API?
No public API is recorded for Kudo Biotechnology.
What industry is Kudo Biotechnology in?
Kudo Biotechnology's product category is mRNA Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAF, mRNA/LNP & Nucleic Acid Therapeutics CDMO, with a secondary code of HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA). Its NAICS code is 325414 and its SIC code is 2833.